로딩 중…
지수 로딩 중…
OptimizeRx Corporation
OPRX· NASDAQ· Health Care· Health Care Equipment & Services
$9.39+0.75%
2026-11-02
Financials
Valuation Metrics
OptimizeRx Corporation's Market Cap is $176M. At end of 2025 it was $229M. Ranked #3006 of 3,118 in US market (top 96%), #1380 of 1,474 on NASDAQ (top 94%), #191 of 203 in Health Care Equipment & Services (top 94%) by Market Cap.
Investment Metrics(as of 2026-11-02)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $176M | US#3,006/3,118 Sec#191/203 |
| Revenue | $99M | US#2,674/3,118 Sec#186/203 |
| Net Income | $5M | US#2,198/3,118 Sec#118/203 |
| Total Assets | $164M | US#3,011/3,118 Sec#192/203 |
| Net Assets | $131M | US#2,759/3,118 Sec#172/203 |
| Employees | 133 | US#2,562/3,118 Sec#178/203 |
| Value | ||
| P/E | 38.30x | US#1,767/3,118 Sec#80/203 |
| P/B | 1.34x | US#759/3,118 Sec#31/203 |
| P/S | 1.79x | US#1,180/3,118 Sec#82/203 |
| EV/EBITDA | 11.00x | US#959/3,118 Sec#28/203 |
| FCF Yield | 10.42% | US#538/3,118 Sec#15/203 |
| Profitability | ||
| ROE | 3.51% | US#1,912/3,118 Sec#97/203 |
| ROA | 2.80% | US#1,458/3,118 Sec#94/203 |
| Op. Margin | 11.45% | US#1,465/3,118 Sec#66/203 |
| Revenue Growth | -5.82% | US#2,457/3,118 Sec#185/203 |
| Financial Health | ||
| Debt Ratio | 25.35% | US#279/3,118 Sec#29/203 |
| Total Debt | $19M | US#2,747/3,118 Sec#173/203 |
| FCF | $18M | US#2,173/3,118 Sec#135/203 |
| Cash | $24M | US#2,811/3,118 Sec#186/203 |
| Current Ratio | 5.58x | US#417/3,118 Sec#33/203 |
| Net Debt/EBITDA | -0.30x | US#474/3,118 Sec#39/203 |
| Performance | ||
| 1Y Return | -54.17% | US#2,898/3,118 Sec#189/203 |
| 1M Return | 9.57% | US#655/3,118 Sec#51/203 |
| From 52W High | -52.31% | US#2,755/3,118 Sec#184/203 |
| 1Y MDD | -76.30% | US#3,008/3,118 Sec#194/203 |
| Trading | ||
| Volume | 140,052 shares | US#2,791/3,118 Sec#189/203 |
| Trading Value | $1M | US#2,972/3,118 Sec#188/203 |
| Per Share | ||
| EPS | $0.25 | US#2,002/3,118 Sec#111/203 |
| BPS | $6.99 | US#2,085/3,118 Sec#125/203 |
Company Info
OptimizeRx Corp. is digital health company, engaged in the provision of digital health messaging via electronic health records, which serve as a direct channel for pharmaceutical companies to communicate with healthcare providers. It offers electronic health record (EHR) workflow solutions which include financial messaging, patient education, and brand messaging and brand support. The company was founded by David A. Harrell in 2006 and is headquartered in Waltham, MA.